Allen Omid Eghrari, MD, MPH

Ruth Tessema, M.D., is an ophthalmologist at the Wilmer Eye Institute, Johns Hopkins Medicine Howard County and Frederick locations. She earned her medical degree from Howard University and completed her ophthalmology residency at the UC Davis Eye Center. Before joining the Wilmer Eye Institute, she worked as an ophthalmologist with Kaiser Permanente in California. A lifelong interest in science and a passion for helping people live healthy, full lives led Dr. Tessema into medicine and the field of ophthalmology. She approaches care with the recognition that eyesight is vital to patient well-being and independence, and she strives to be a patient advocate, to remove systemic barriers to quality care and to protect the health and dignity of everyone she works with. Dr. Tessema has clinical experience in cataract surgery, glaucoma management, diabetic eye disease, dry eye treatment, and eyelid and ocular surface disorders.

Bryce Chiang, M.D., Ph.D., is an assistant professor of ophthalmology and a glaucoma specialist at the Wilmer Eye Institute, Johns Hopkins Medicine East Baltimore location. His clinical interests include the medical and surgical management of glaucoma and cataract. After receiving his combined bachelor’s/master’s degrees in biomedical engineering from The Johns Hopkins University, Dr. Chiang completed joint M.D./Ph.D. degrees at the Emory University School of Medicine. During his doctorate in biomedical engineering at the Georgia Institute of Technology, Dr. Chiang became interested in ophthalmology through his research in ocular drug delivery. He served as a medicine intern at Highland Hospital in Oakland, California, and completed his ophthalmology residency, glaucoma fellowship and innovation fellowship at the Byers Eye Institute at Stanford University. Dr. Chiang’s research interests include targeted ocular drug delivery, specifically within the suprachoroidal space and to the optic nerve head. He studied the pharmacokinetics of microneedle injections into the suprachoroidal space while pursuing his doctorate at Georgia Tech, and maintains an interest in the suprachoroidal space as a means of altering disease trajectory. Furthermore, despite the optic nerve head being the site of disease in optic neuropathies, no therapies exist that treat the optic nerve head. By directly treating the diseased tissue, targeting therapeutics to the optic nerve head may enable paradigm shifting therapies for optic neuropathies. Targeted delivery to the optic nerve head may also serve as a research tool to query the pathogenesis of glaucoma.

Andrew R. Carey, MD is a the Neil R. Miller Rising Professor of Ophthalmology in the division of Neuro-Ophthalmology at the Wilmer Eye Institute. He specializes in neuro-ophthalmic disorders such as optic neuritis, uveitis related papillitis, ischemic & hereditary optic neuropathies as well as diseases of the retina, including age-related macular degeneration, diabetic retinopathy, toxic retinopathies and inherited disorders of the retina such as retinitis pigmentosa. Dr. Carey’s clinical and research interests include comparative effectiveness and cost-benefit of intravitreal medications, long-term outcome of treatments for choroidal neovascularization, novel treatments for papillitis, and the use of novel imaging modalities to better diagnose and understand optic nerve and retinal diseases. Dr. Carey received his bachelor's from Davidson College in mathematics in 2006. In 2010, he received his medical degree from the University of South Florida. He completed his ophthalmology residency as Chief Resident in 2014 at the University of South Florida. He then went on to complete his fellowship in neuro-ophthalmology at Bascom Palmer Eye Institute in 2015 and his fellowship in medical retina at the University of Iowa in 2016.